BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 7, 2004
View Archived Issues
Isovaleramide advances into phase IIa study in migraine
Read More
Phase Ib study evaluates aerosolized surfactant therapy for asthma
Read More
Axonyx expands scope of phenserine phase IIb clinical trial
Read More
Confirmatory data supports phase II Resten-NG data
Read More
Five years exclusive Indian marketing rights for Nadoxin
Read More
Uni-Gold Recombigen HIV test receives FDA approval
Read More
Symbyax approved for bipolar depressive episodes
Read More
NDA submission for once-daily Allegra-D
Read More
ISIS-301012 enters phase I study for treatment of cardiovascular disease
Read More
Pharmion submits Vidaza NDA
Read More
Neurodex evaluated for pseudobulbar affect
Read More
Aventis scientists prepare and test new cathepsin K inhibitors
Read More
Kirin Brewery presents new inhibitors of Bcl-2/Bcl-xL with utility in cancer therapy
Read More
Novel libraries of antibacterial compounds prepared at Lion Bioscience
Read More
Mitsui Chemicals patent covers new agents for telomerase-mediated disorders
Read More
New antitumor azoles in early development at Sankyo
Read More
Coremed plans clinical trials for Alveair insulin technology
Read More
Alvesco NDA submission for persistent asthma
Read More
Shipments of TriNessa commence
Read More
DX-88 meets primary endpoints in phase I/II study
Read More
Japanese trials of HGF genetic medicine cleared to begin
Read More
Nascobal Nasal Spray submitted for FDA approval
Read More
AVI-4020 safe in phase I/II West Nile trial
Read More
Kyorin discontinues development of KRP-297
Read More
NDA filing for Arcoxia
Read More
Ivabradine has no adverse effects on the LVEF of patients with left ventricular dysfunction
Read More
Prolonged inhibition of spermatogenesis found with subcutaneous MENT implants
Read More
A novel triple therapy improves glucose metabolism in obese patients with type 2 diabetes
Read More